Order Article Reprints

Zajączkowska R, Pawlik K, Ciapała K, Piotrowska A, Ciechanowska A, Rojewska E, Kocot-Kępska M, Makuch W, Wordliczek J, Mika J. Mirogabalin Decreases Pain-like Behaviors by Inhibiting the Microglial/Macrophage Activation, p38MAPK Signaling, and Pronociceptive CCL2 and CCL5 Release in a Mouse Model of Neuropathic Pain. Pharmaceuticals. 2023; 16(7):1023. https://doi.org/10.3390/ph16071023

Zajączkowska, Renata, Katarzyna Pawlik, Katarzyna Ciapała, Anna Piotrowska, Agata Ciechanowska, Ewelina Rojewska, Magdalena Kocot-Kępska, Wioletta Makuch, Jerzy Wordliczek, and Joanna Mika. 2023. "Mirogabalin Decreases Pain-like Behaviors by Inhibiting the Microglial/Macrophage Activation, p38MAPK Signaling, and Pronociceptive CCL2 and CCL5 Release in a Mouse Model of Neuropathic Pain" Pharmaceuticals 16, no. 7: 1023. https://doi.org/10.3390/ph16071023

Zajączkowska, R., Pawlik, K., Ciapała, K., Piotrowska, A., Ciechanowska, A., Rojewska, E., Kocot-Kępska, M., Makuch, W., Wordliczek, J., & Mika, J. (2023). Mirogabalin Decreases Pain-like Behaviors by Inhibiting the Microglial/Macrophage Activation, p38MAPK Signaling, and Pronociceptive CCL2 and CCL5 Release in a Mouse Model of Neuropathic Pain. Pharmaceuticals, 16(7), 1023. https://doi.org/10.3390/ph16071023